For the purpose of this Article VII, the following terms shall have the definitions ascribed to them:
All waste generated by or resulting from the production or use of antineoplastic agents used for the purpose of stopping or reversing the growth of malignant cells. Chemotherapeutic waste shall not include any waste containing antineoplastic agents that are listed as hazardous waste under 25 Pa. Code § 75.261 (relating to criteria, identification and listing of hazardous waste).
The same as "hazardous waste" under the federal regulations promulgated by the United States Environmental Protection Agency and codified at 40 CFR 261.3. 40 CFR 261.3 is incorporated herein by reference. All lists in 40 CFR Part 261, Subpart D, and the Appendices to Part 261 are also expressly incorporated by reference. The term "hazardous waste" as used herein also includes any substance or mixture containing polychlorinated biphenyls ("PCB's") at greater than 1/10 of 1% concentration when such substance or mixture is not intended for beneficial use or reuse. Radioactive waste and by-products, as defined by the Code of Pennsylvania 1975, are expressly excluded from this definition.
Discard generated at a hospital, except unused items returned to the manufacturer. The definition of "hospital waste" does not include human corpses, remains, and anatomical parts that are intended for interment or cremation.
Any waste that may contain pathogens capable of causing an infectious disease and shall include, but not be limited to, the following wastes: infectious isolation waste; cultures and stocks of infectious agents; blood, blood products and body fluids; pathological waste; contaminated sharps; and contaminated animal carcasses, body parts and bedding.
The holding of infectious waste for a temporary period, at the end of which the infectious waste is treated, disposed of, moved, or stored elsewhere.